Infectious mononucleosis: Return to play

Clinics in Sports Medicine

Volumn 23, Issue 3, 2004, Pages 485-497

  Auwaerter, Paul G ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JHCP at Green Spring Station   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; CORTICOSTEROID;

ATHLETE; CLINICAL FEATURE; CONFERENCE PAPER; CONVALESCENCE; EPSTEIN BARR VIRUS; HUMAN; IMMUNOASSAY; INFECTIOUS MONONUCLEOSIS; NEUROLOGICAL COMPLICATION; SEROLOGY; SPLEEN RUPTURE; SPORT; VIRUS TRANSMISSION;

HUMANS; INFECTIOUS MONONUCLEOSIS; RECOVERY OF FUNCTION; SPORTS; SPORTS MEDICINE;

EID: 3242671485     PISSN: 02785919     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.csm.2004.02.005     Document Type: Conference Paper

References (68)

1. Epstein M.A., Achong B.G., Barr Y.M. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet. 1:1964;702-703
2. Macsween K.F., Crawford D.H. Epstein-Barr virus - recent advances. Lancet Infect Dis. 3(3):2003;131-140
3. Hjalgrim H., Askling J., Rostgaard K., et al. Characteristics of Hodgkin's lymphoma after infectious mononucleosis. N Engl J Med. 349(14):2003;1324-1332
4. Hoagland R.J. Infectious mononucleosis. 1967;Grune & Stratton, New York
5. Yao Q.Y., Rickinson A.B., Epstein M.A. A re-examination of the Epstein-Barr virus carrier state in healthy seropositive individuals. Int J Cancer. 35(1):1985;35-42
6. Cohen J.I. Epstein-Barr virus infection. N Engl J Med. 343(7):2000;481-490
7. Baumgarten E., Herbst H., Schmitt M., et al. Life-threatening infectious mononucleosis: is it correlated with virus- induced T cell proliferation? Clin Infect Dis. 19(1):1994;152-156
8. Henle G., Henle W., Clifford P. Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups. J Nat Cancer Inst. 43:1969;1147-1157
9. Fleisher G.R., Pasquariello P.S., Warren W.S., et al. Intrafamilial transmission of Epstein-Barr virus infections. J Pediatr. 98(1):1981;16-19
10. Biggar R.J., Henle G., Bocker J., et al. Primary Epstein-Barr virus infections in African infants. II. Clinical and serological observations during seroconversion. Int J Cancer. 22(3):1978;244-250
11. Anonymous Infectious mononucleosis and its relationship to EB virus antibody: a joint investigation by university health physicians and PHLS laboratories. BMJ. 4:1971;643-646
12. Niederman J.C., Evans A.S., Subrahmanyan L., et al. Prevalence, incidence and persistence of EB virus antibody in young adults. N Engl J Med. 282:1970;361-365
13. Sawyer R.N., Evans A.S., Niederman J.C., et al. Prospective studies of a group of Yale freshman. 1. Occurrence of infectious mononucleosis. J Infect Dis. 123:1971;263-270
14. Maki D.G., Reich R.M. Infectious mononucleosis in the athlete. Diagnosis, complications, and management. Am J Sports Med. 10(3):1982;162-173
15. Auwaerter P.G. Infectious mononucleosis in middle age [clinical conference]. JAMA. 281(5):1999;454-459
16. Morris M.C., Edmunds W.J. The changing epidemiology of infectious mononucleosis? J Infect. 45(2):2002;107-109
17. Morris M.C., Edmunds W.J., Hesketh L.M., et al. Sero-epidemiological patterns of Epstein-Barr and herpes simplex (HSV-1 and HSV-2) viruses in England and Wales. J Med Virol. 67(4):2002;522-527
18. Crawford D.H., Swerdlow A.J., Higgins C., et al. Sexual history and Epstein-Barr virus infection. J Infect Dis. 186(6):2002;731-736
19. Hoagland R.J. The incubation period of infectious mononucleosis. Am J Public Health. 54:1964;1699-1705
20. Mason W.R. Jr., Adams E.K. Infectious mononucleosis; an analysis of 100 cases with particular attention to diagnosis, liver function tests and treatment of selected cases with prednisone. Am J Med Sci. 236(4):1958;447-459
21. Linde A. Diagnosis of Epstein-Barr virus-related diseases. Scand J Infect Dis. 100(Suppl):1996;83-88
22. Schooley R.T. Epstein-Barr Virus (infectious mononucleosis). Mandel G.L., Bennett J.E., Dolin R. Principles and pactice of infectious diseases. 4th edition:1995;1364-1377 Churchill Livingstone, New York
23. Grotto I., Mimouni D., Huerta M., et al. Clinical and laboratory presentation of EBV positive infectious mononucleosis in young adults. Epidemiol Infect. 131(1):2003;683-689
24. Chetham M.M., Roberts K.B. Infectious mononucleosis in adolescents. Pediatr Ann. 20(4):1991;206-213
25. Rush M.C., Simon M.W. Occurrence of Epstein-Barr virus illness in children diagnosed with group A streptococcal pharyngitis. Clin Pediatr (Phila). 42(5):2003;417-420
26. Dommerby H., Stangerup S.E., Stangerup M., et al. Hepatosplenomegaly in infectious mononucleosis, assessed by ultrasonic scanning. J Laryngol Otol. 100(5):1986;573-579
27. Pullen H., Wright N., Murdoch J.M. Hypersensitivity reactions to antibacterial drugs in infectious mononucleosis. Lancet. 2(7527):1967;1176-1178
28. Ross J., Cohen J. Epstein-Barr virus. Scheld W.M., Whitley R.J., Durack D.T. Infections of the central nervous system. 2nd edition:1997;117-127 Lippincott-Raven, Philadelphia
29. Baron D.N., Bell J.L., Dunnet W.N. Biochemical studies on hepatic involvement in infectious mononucleosis. J Clin Pathol. 18:1965;209-211
30. Fleisher G.R., Collins M., Fager S. Limitations of available tests for diagnosis of infectious mononucleosis. J Clin Microbiol. 17(4):1983;619-624
31. Sumaya C.V. Endogenous reactivation of Epstein-Barr virus infections. J Infect Dis. 135(3):1977;374-379
32. Okano M., Thiele G.M., Davis J.R., et al. Epstein-Barr virus and human diseases: recent advances in diagnosis. Clin Microbiol Rev. 1(3):1988;300-312
33. Candy B., Chalder T., Cleare A.J., et al. Recovery from infectious mononucleosis: a case for more than symptomatic therapy? A systematic review. Br J Gen Pract. 52(483):2002;844-851
34. Lloyd A.R., Hales J.P., Gandevia S.C. Muscle strength, endurance and recovery in the post-infection fatigue syndrome. J Neurol Neurosurg Psychiatry. 51(10):1988;1316-1322
35. van der Horst C., Joncas J., Ahronheim G., et al. Lack of effect of peroral acyclovir for the treatment of acute infectious mononucleosis. J Infect Dis. 164(4):1991;788-792
36. Torre D., Tambini R. Acyclovir for treatment of infectious mononucleosis: a meta-analysis. Scand J Infect Dis. 31(6):1999;543-547
37. Foss H.D., Herbst H., Hummel M., et al. Patterns of cytokine gene expression in infectious mononucleosis. Blood. 83(3):1994;707-712
38. Straus S.E., Cohen J.I., Tosato G., et al. NIH conference. Epstein-Barr virus infections: biology, pathogenesis, and management. Ann Intern Med. 118(1):1993;45-58
39. Tynell E., Aurelius E., Brandell A., et al. Acyclovir and prednisolone treatment of acute infectious mononucleosis: a multicenter, double-blind, placebo-controlled study. J Infect Dis. 174(2):1996;324-331
40. McGowan J.E. Jr., Chesney P.J., Crossley K.B., et al. Guidelines for the use of systemic glucocorticosteroids in the management of selected infections. Working Group on Steroid Use, Antimicrobial Agents Committee, Infectious Diseases Society of America. J Infect Dis. 165(1):1992;1-13
41. Farley D.R., Zietlow S.P., Bannon M.P., et al. Spontaneous rupture of the spleen due to infectious mononucleosis [see comments]. Mayo Clin Proc. 67(9):1992;846-853
42. Stockinger Z.T. Infectious mononucleosis presenting as spontaneous splenic rupture without other symptoms. Mil Med. 168(9):2003;722-724
43. Rutkow I.M. Rupture of the spleen in infectious mononucleosis: a critical review. Arch Surg. 113(6):1978;718-720
44. Schuler J.G., Filtzer H. Spontaneous splenic rupture. The role of nonoperative management. Arch Surg. 130(6):1995;662-665
45. Asgari M.M., Begos D.G. Spontaneous splenic rupture in infectious mononucleosis: a review. Yale J Biol Med. 70(2):1997;175-182
46. Pachter H.L., Guth A.A., Hofstetter S.R., et al. Changing patterns in the management of splenic trauma: the impact of nonoperative management. Ann Surg. 227(5):1998;708-717. discussion: 717-9
47. Schwarz M., Zaidenstein L., Freud E., et al. Spontaneous splenic rupture in infectious mononucleosis: conservative management with gradual percutaneous drainage of a subcapsular hematoma. Pediatr Surg Int. 15(2):1999;139-140
48. Jenson H.B. Acute complications of Epstein-Barr virus infectious mononucleosis. Curr Opin Pediatr. 12(3):2000;263-268
49. Connelly K.P., DeWitt L.D. Neurologic complications of infectious mononucleosis. Pediatr Neurol. 10(3):1994;181-184
50. Godshall S.E., Kirchner J.T. Infectious mononucleosis. Complexities of a common syndrome. Postgrad Med 2000;107(7):175-9; 183-4; 186
51. Rea T.D., Russo J.E., Katon W., et al. Prospective study of the natural history of infectious mononucleosis caused by Epstein-Barr virus. J Am Board Fam Pract. 14(4):2001;234-242
52. Candy B., Chalder T., Cleare A.J., et al. Predictors of fatigue following the onset of infectious mononucleosis. Psychol Med. 33(5):2003;847-855
53. Katon W., Russo J., Ashley R.L., et al. Infectious mononucleosis: psychological symptoms during acute and subacute phases of illness [see comments]. Gen Hosp Psychiatry. 21(1):1999;21-29
54. Krilov L.R., Fisher M., Friedman S.B., et al. Course and outcome of chronic fatigue in children and adolescents. Pediatrics. 102(2 Pt 1):1998;360-366
55. Whiting P., Bagnall A.M., Sowden A.J., et al. Interventions for the treatment and management of chronic fatigue syndrome: a systematic review. JAMA. 286(11):2001;1360-1368
56. Rao S.G., Bennett R.M. Pharmacological therapies in fibromyalgia. Best Pract Res Clin Rheumatol. 17(4):2003;611-627
57. Eichner E.R. Infectious mononucleosis: recognizing the condition, "reactivating" the patient. Phys Sportsmed. 24(4):1996;49-54
58. Frelinger D.P. The ruptured spleen in college athletes: a preliminary report. J Am Coll Health Assoc. 26(4):1978;217
59. Johnson M.A., Cooperberg P.L., Boisvert J., et al. Spontaneous splenic rupture in infectious mononucleosis: sonographic diagnosis and follow-up. AJR Am J Roentgenol. 136(1):1981;111-114
60. Haines J.D. Jr. When to resume sports after infectious mononucleosis. How soon is safe? Postgrad Med. 81(1):1987;331-333
61. Friman G., Wesslen L. Special feature for the Olympics: effects of exercise on the immune system: infections and exercise in high-performance athletes. Immunol Cell Biol. 78(5):2000;510-522
62. Tamayo S.G., Rickman L.S., Mathews W.C., et al. Examiner dependence on physical diagnostic tests for the detection of splenomegaly: a prospective study with multiple observers. J Gen Intern Med. 8(2):1993;69-75
63. Ali J. Spontaneous rupture of the spleen in patients with infectious mononucleosis. Can J Surg. 36(1):1993;49-52
64. Lamb P.M., Lund A., Kanagasabay R.R., et al. Spleen size: how well do linear ultrasound measurements correlate with three-dimensional CT volume assessments? Br J Radiol. 75(895):2002;573-577
65. Burroughs K.E. Athletes resuming activity after infectious mononucleosis. Arch Fam Med. 9(10):2000;1122-1123
66. Oski F.A. Management of a football player with infectious mononucleosis. Pediatr Infect Dis J. 13(10):1994;938-939
67. McIntyre O.R., Ebaugh F.G. Jr. Palpable spleens in college freshmen. Ann Intern Med. 66(2):1967;301-306
68. Noffsinger J. Physical activity considerations in children and adolescents with viral infections. Pediatr Ann. 25(10):1996;585-589